Endocrinology, Vol 113, 687-692, Copyright © 1983 by Endocrine Society

ARTICLES

Evidence that beta 1-adrenoceptor activation mediates isoproterenol- stimulated renin secretion in the rat

PC Churchill, MC Churchill and FD McDonald

The goal of these experiments was to determine if isoproterenol- stimulated renin secretion in the rat is mediated by activation of beta 1- and/or beta 2-adrenoceptors. The rat renal cortical slice preparation was used. The renin secretory rate was a sigmoid function of the logarithm of the isoproterenol concentration; half-maximal and maximal stimulation occurred at approximately 0.01 and 0.1 microM isoproterenol, respectively. Neither timolol (a nonselective beta- antagonist) nor atenolol (a beta 1-selective antagonist) had a significant effect on basal secretory rate, but both shifted the isoproterenol dose-response curve to the right without changing its slope, suggesting competitive antagonism. Timolol was the more potent, but the response to a maximally effective concentration of isoproterenol could be blocked by timolol (0.9 microM), atenolol (110 microM), or a combination of the two (0.45 microM timolol plus 55 microM atenolol). This latter finding is consistent with action of the two antagonists at one and the same site. If it is assumed that timolol antagonizes both beta 1- and beta 2-adrenoceptors and that atenolol antagonizes only beta 1-adrenoceptors, it follows that isoproterenol- stimulated renin secretion in this preparation is mediated by activation of beta 1-adrenoceptors.

This article has been cited by other articles:

				F. Vargas, J. M. Moreno, I. Rodriguez-Gomez, R. Wangensteen, A. Osuna, M. Alvarez-Guerra, and J. Garcia-Estan Vascular and renal function in experimental thyroid disorders Eur. J. Endocrinol., February 1, 2006; 154(2): 197 - 212. [Abstract] [Full Text] [PDF]

				A. Rapacciuolo, G. Esposito, K. Caron, L. Mao, S. A. Thomas, and H. A. Rockman Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy J. Am. Coll. Cardiol., September 1, 2001; 38(3): 876 - 882. [Abstract] [Full Text] [PDF]